A.B. v. HHS - MMR, immune thrombocytopenic purpura (ITP) (2025)
Case summary [AI summaries can sometimes make mistakes]
On March 29, 2023, the petitioner filed for compensation on behalf of A.B., a minor child, alleging that A.B. developed immune thrombocytopenic purpura (ITP) after receiving measles, mumps, and rubella (MMR) on July 9, 2020. Respondent denied that A.B. sustained a Table ITP injury, denied vaccine causation, and denied vaccine-related sequelae.
The public stipulation identifies A.B. as a minor child but does not state her exact age, date of birth, platelet counts, bleeding symptoms, hospital care, or treatment. On April 11, 2025, Special Master Thomas L.
Gowen adopted the parties' stipulation or proffer, found the disposition reasonable on the record before the Court, and awarded $125,000.00 to purchase an annuity contract. Petitioner was represented by Edward Kraus, Kraus Law Group, LLC, Chicago, IL.
Theory of causation
measles, mumps, and rubella (MMR) vaccine on July 9, 2020 (minor child; exact age not stated) allegedly causing immune thrombocytopenic purpura (ITP). COMPENSATED. Respondent denied that A.B. sustained a Table ITP injury, denied vaccine causation, and denied vaccine-related sequelae. The public stipulation identifies A.B. as a minor child but does not state her exact age, date of birth, platelet counts, bleeding symptoms, hospital care, or treatment. Award/status: $125,000.00 to purchase an annuity contract. Special Master Thomas L. Gowen; petition filed March 29, 2023; decision April 11, 2025. Attorney: Edward Kraus, Kraus Law Group, LLC, Chicago, IL. No expert causation analysis in public stipulation/proffer.
Source PDFs
USCOURTS-cofc-1_23-vv-00439